Translational Development Acquisition Corp. Files 2024 10-K
Ticker: TDACW · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1926599
Sentiment: neutral
Topics: 10-K, SPAC, financials
TL;DR
TDAC filed its 2024 10-K. All systems go for SPAC operations.
AI Summary
Translational Development Acquisition Corp. filed its 10-K for the fiscal year ending December 31, 2024. The company, identified by Central Index Key 0001926599, is a blank check company operating in the Real Estate & Construction sector. Its business address is located at 52 E 83RD ST., New York, NY 10028.
Why It Matters
This filing provides a comprehensive overview of Translational Development Acquisition Corp.'s financial performance and operational status for the fiscal year 2024, crucial for investors assessing the company's trajectory.
Risk Assessment
Risk Level: low — The filing is a standard annual report for a SPAC, providing routine financial and operational disclosures.
Key Numbers
- 4,657,500 — Financial Value (A significant financial figure reported in the filing.)
Key Players & Entities
- Translational Development Acquisition Corp. (company) — Filer of the 10-K
- 0001926599 (company) — Central Index Key
- 20241231 (date) — Fiscal year end
- 52 E 83RD ST., New York, NY 10028 (address) — Business and Mail Address
- 4657500 (dollar_amount) — Financial value related to the company
FAQ
What is the primary business of Translational Development Acquisition Corp.?
Translational Development Acquisition Corp. is a blank check company operating in the Real Estate & Construction sector, as indicated by its SIC code [6770].
What is the filing date and the period it covers?
The filing date is March 31, 2025, and it covers the fiscal year ending December 31, 2024.
Where is Translational Development Acquisition Corp. located?
The company's business and mailing address is 52 E 83RD ST., New York, NY 10028.
What are some of the key dates mentioned in relation to share classes?
Key dates mentioned for Founder Shares (Class B) include October 15, 2024, August 29, 2024, and May 25, 2022.
What is the company's SEC file number?
The SEC file number for Translational Development Acquisition Corp. is 001-42451.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Translational Development Acquisition Corp. (TDACW).